136 related articles for article (PubMed ID: 2127509)
1. Silent renal microangiography after mitomycin C therapy.
Poch E; González-Clemente JM; Torras A; Darnell A; Botey A; Revert L
Am J Nephrol; 1990; 10(6):514-7. PubMed ID: 2127509
[TBL] [Abstract][Full Text] [Related]
2. Mitomycin-associated renal failure. Case report and review.
Hamner RW; Verani R; Weinman EJ
Arch Intern Med; 1983 Apr; 143(4):803-7. PubMed ID: 6340628
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary hypertension, hemolytic anemia, and renal failure. A mitomycin-associated syndrome.
McCarthy JT; Staats BA
Chest; 1986 Apr; 89(4):608-11. PubMed ID: 3082608
[TBL] [Abstract][Full Text] [Related]
4. [Complete response in a case of unresectable gastric cancer with a combination of tegafur, 5-fluorouracil and mitomycin C].
Sasaki Y; Sasaki J; Ito T; Nehashi Y
Gan To Kagaku Ryoho; 1988 Sep; 15(9):2793-5. PubMed ID: 3137891
[TBL] [Abstract][Full Text] [Related]
5. Microangiopathic hemolytic anemia, renal failure, and noncardiogenic pulmonary edema: a chemotherapy-induced syndrome.
Jolivet J; Giroux L; Laurin S; Gruber J; Bettez P; Band PR
Cancer Treat Rep; 1983 May; 67(5):429-34. PubMed ID: 6406059
[TBL] [Abstract][Full Text] [Related]
6. [A case report of hemolytic uremic syndrome (HUS) induced by antineoplastic agents].
Anai H; Okada Y; Okubo K; Korenaga D; Maehara Y; Sugimachi K; Ohi Y
Nihon Gan Chiryo Gakkai Shi; 1990 Jul; 25(7):1487-91. PubMed ID: 2120375
[TBL] [Abstract][Full Text] [Related]
7. [Microangiopathic hemolytic anemia (MAHA) observed after administration of mitomycin C (MMC)].
Yasunaga C; Komota T; Mimura K; Kinjyo M; Sueishi K; Hirose T
Gan No Rinsho; 1987 Jun; 33(7):854-60. PubMed ID: 3112442
[TBL] [Abstract][Full Text] [Related]
8. [Microangiopathic hemolytic anemia (MAHA) and renal failure induced by anti-neoplastic agents--a case report].
Sagawa M; Sakuma T; Takahashi S; Usuda K; Satoh M; Kamma K; Ohta S; Nagamoto N; Imai T; Saitoh Y
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2564-7. PubMed ID: 3039922
[TBL] [Abstract][Full Text] [Related]
9. [Mytomycin C nephrotoxicity. 3 new cases and review of the literature].
Simon P; Hervé JP; Ramée MP; Leroy JP; Ang KS; Leguy P; Vignoud J; Cledes J
Nephrologie; 1982; 3(4):152-7. PubMed ID: 6818483
[TBL] [Abstract][Full Text] [Related]
10. Renal failure and hemolytic anemia associated with mitomycin C. A case report.
Price TM; Murgo AJ; Keveney JJ; Miller-Hardy D; Kasprisin DO
Cancer; 1985 Jan; 55(1):51-6. PubMed ID: 3917354
[TBL] [Abstract][Full Text] [Related]
11. Microangiopathic hemolytic anemia, noncardiac pulmonary edema, and renal failure after treatment of metastatic adenocarcinoma of the colon with 5-fluorouracil and mitomycin-C: report of a case.
Claycomb CL; Berkovic M
J Am Osteopath Assoc; 1986 Aug; 86(8):499-503. PubMed ID: 3093413
[No Abstract] [Full Text] [Related]
12. [Combination chemotherapy of advanced gastric cancer with adriamycin, mitomycin C, and ftorafur].
Miyamoto H; Ogawa M; Inagaki J; Horikoshi N; Ezaki K; Inoue K; Ikeda K; Usui N; Nakada H; Okada Y
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1160-4. PubMed ID: 6408998
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary veno-occlusive disease associated with microangiopathic hemolytic anemia and chemotherapy of gastric adenocarcinoma.
Waldhorn RE; Tsou E; Smith FP; Kerwin DM
Med Pediatr Oncol; 1984; 12(6):394-6. PubMed ID: 6548790
[TBL] [Abstract][Full Text] [Related]
14. Randomized trial of adjuvant chemotherapy with mitomycin plus ftorafur versus mitomycin alone in resected locally advanced gastric cancer.
Grau JJ; Estapé J; Fuster J; Filella X; Visa J; Terés J; Soler G; Albiol S; García-Valdecasas JC; Grande L; Bombí J; Bordas J; Alcobendas F
J Clin Oncol; 1998 Mar; 16(3):1036-9. PubMed ID: 9508188
[TBL] [Abstract][Full Text] [Related]
15. [Microangiopathic haemolytic anaemia as a complication of mitomycin C treatment (author's transl)].
Tigges FJ; Bruntsch U; Groos G; Gallmeier WM
Dtsch Med Wochenschr; 1982 Jan; 107(4):142-5. PubMed ID: 7056168
[TBL] [Abstract][Full Text] [Related]
16. Renal toxicity of mitomycin-C.
Ravikumar TS; Sibley R; Reed K; Grage TB
Am J Clin Oncol; 1984 Jun; 7(3):279-85. PubMed ID: 6428215
[TBL] [Abstract][Full Text] [Related]
17. [Hemolytic-uremic syndrome caused by mitomycin C].
de Insausti CL; Gutiérrez LE
Sangre (Barc); 1988 Aug; 33(4):319-20. PubMed ID: 3142062
[No Abstract] [Full Text] [Related]
18. Renal disease after mitomycin C therapy.
Hanna WT; Krauss S; Regester RF; Murphy WM
Cancer; 1981 Dec; 48(12):2583-8. PubMed ID: 6796250
[TBL] [Abstract][Full Text] [Related]
19. [Combination cancer chemotherapy of human gastric and colon carcinomas in nude mice--sequential cancer chemotherapy involving mitomycin C and tegafur].
Kubota T; Ishibiki K; Abe O
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):938-44. PubMed ID: 3083789
[TBL] [Abstract][Full Text] [Related]
20. A syndrome of microangiopathic hemolytic anemia, renal impairment, and pulmonary edema in chemotherapy-treated patients with adenocarcinoma.
Sheldon R; Slaughter D
Cancer; 1986 Oct; 58(7):1428-36. PubMed ID: 3091244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
